Picard Medical Releases Stockholder Presentation; Highlights Q1 Revenue Growth

Picard Medical, Inc. filed an amended Form 8-K to replace a previously furnished press release with a corrected version. The corrected press release announces the availability of a pre-recorded presentation for its 2026 Annual Meeting of Stockholders, highlighting significant business progress and product development milestones. Key updates include an 85% year-over-year revenue increase for Q1 2026, a 116% rise in U.S. revenue, and a gross margin of 24% for the same period. The company also provided updates on its next-generation Emperor platform, with plans for an IDE submission in 2028 and clinical studies in 2029.